<DOC>
	<DOCNO>NCT00522223</DOCNO>
	<brief_summary>Primary Objectives : 1 . To assess entire range sexual functioning ( desire , arousal , orgasmic capacity , dyspareunia , sexual satisfaction ) course treatment early follow-up patient local locally advanced cervical cancer ; 2 . To assess general cancer-related QOL course treatment early follow-up patient local locally advanced cervical cancer ; 3 . To characterize relationship sexual dysfunction overall cancer-related QOL time ; 4 . To identify factor may predict good sexual function outcomes patient treated cervical cancer . Secondary Objectives : 1 . Describe vaginal change objectively via measurement vaginal length . 2 . Demonstrate reliability vaginal length instrument applicability future study .</brief_summary>
	<brief_title>Sexual Functioning Cervical Cancer Survivors</brief_title>
	<detailed_description>FIRST PART : NO LONGER RECRUITING There two part study . The first part call `` feasibility study '' include 20 woman treat cervix cancer past . These woman ask fill questionnaire evaluate quality life sexual functioning . The questionnaire complete . The questionnaire fill routine clinic visit . SECOND PART : RECRUITING If feasibility study successful ( majority 20 woman able complete questionnaire ) , second part study perform large number woman diagnose cervix cancer yet begin treatment . Patients participate part study also ask fill questionnaire describe . Participants treat radiation therapy ask complete questionnaire 5 time : radiation treatment start , time first ALTO , 1 month , 4 month 7 month treatment end . Vaginal measurement do 4 time : time first ALTO , 1 month , 4 month 7 month treatment end . Participants undergo radical hysterectomy ask complete questionnaire vaginal measurement 4 time : surgery 1 month , 4 month 7 month treatment end . Vaginal measurement do 4 time : time first ALTO , 1 month , 4 month 7 month treatment end . The questionnaire take 20 minute complete . The vaginal measurement do doctor take less minute complete . This investigational study . About 165 patient take part multicenter study . About 135 patient enrol M. D. Anderson .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>1 . Eligibility criteria 20 woman pilot study ( see Treatment Plan detail ) feasibility include : History cervical cancer ( within 3 month 5 year diagnosis ) English Spanishspeaking Ability give inform consent 2 . Eligibility criterion main study : New diagnosis local locally advanced cervical cancer English Spanishspeaking Ability give inform consent 1 . Patients illiterate 2 . Patients undergone exenteration 3 . Patients speak English Spanish</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Cervical Cancer</keyword>
	<keyword>Cancer Survivors</keyword>
	<keyword>Cervix Cancer</keyword>
	<keyword>Sexual Functioning</keyword>
	<keyword>Quality Of Life</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Radiation Therapy</keyword>
	<keyword>Radical Hysterectomy</keyword>
</DOC>